Detalhe da pesquisa
1.
Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication.
Curr Opin Hematol
; 30(2): 30-37, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728601
2.
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.
Blood
; 138(21): 2093-2105, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125889
3.
Using real-world evidence in haematology.
Best Pract Res Clin Haematol
; 37(1): 101536, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490764
4.
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.
J Clin Oncol
; : JCO2302175, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723212
5.
MOSAIC: An Artificial Intelligence-Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare Cancers.
JCO Clin Cancer Inform
; 8: e2400008, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38875514
6.
Thyroid dysfunction in children and adolescents affected by undernourished and overnourished eating disorders.
Front Nutr
; 10: 1205331, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841407
7.
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology.
JCO Clin Cancer Inform
; 7: e2300021, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390377
8.
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
J Clin Oncol
; 41(15): 2827-2842, 2023 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36930857
9.
The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence.
Blood Rev
; 54: 100914, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996639
10.
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
J Clin Oncol
; 39(11): 1223-1233, 2021 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539200
11.
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms.
Leukemia
; 38(6): 1427-1431, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38632316